Quickstart Highlights

Pinealon (also known as EDR; sequence Glu‑Asp‑Arg) is an ultrashort tripeptide investigated for neuroprotective and epigenetic regulatory effects, with most peer‑reviewed data from in vitro and animal studies and limited human observations^{[1][2][3][4][5]}. Published literature frequently describes oral administration in clinical contexts; subcutaneous (SC) human dosing is not established and the SC framework below is educational for research settings only^[4][5].

• Reconstitute: Add 3.0 mL bacteriostatic water → ~6.67 mg/mL concentration.
• Research-use daily range (educational): 200–500 mcg once daily with gradual titration (SC route not defined in clinical trials; see Evidence note above).
• Insulin‑syringe math: At 6.67 mg/mL, 1 unit = 0.01 mL ≈ 66.7 mcg on a U‑100 insulin syringe.
• Storage: Lyophilized: store at −20 °C (−4 °F) protected from light; after reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F); minimize freeze–thaw cycles^[12][13].

Protocol Overview

Cautious, research‑only framework reflecting current evidence limitations.

• Goal: Study neuroprotective and stress‑response pathways influenced by EDR/Pinealon^[1][3][5].
• Schedule: Once‑daily subcutaneous injections for 8–12 weeks (optional extension to 16 weeks); note oral dosing dominates human literature^[4][5].
• Dose Range: 200–500 mcg daily with gradual titration (educational; not derived from SC clinical trials).
• Reconstitution: 3.0 mL per 20 mg vial (~6.67 mg/mL) for clear syringe conversions.
• Storage: Lyophilized at −20 °C (−4 °F); reconstituted at 2–8 °C (35.6–46.4 °F); avoid repeated freeze–thaw^[12][13].

Dosing Protocol

Suggested titration for measurement practice and exposure control (research‑only).

• Start: 200–300 mcg daily; increase by ~100 mcg every 1–2 weeks as tolerated.
• Target: 400–500 mcg daily by Weeks 5–12.
• Frequency: Once per day (subcutaneous).
• Cycle Length: 8–12 weeks; optional extension to 16 weeks.
• Timing: Any consistent time; rotate injection sites.

Storage Instructions

Proper storage preserves peptide quality.

• Lyophilized: Store at −20 °C (−4 °F) in dry, dark conditions.
• Reconstituted: Refrigerate at 2–8 °C (35.6–46.4 °F); aliquot if needed and avoid freeze–thaw^[12][13].
• Let vials reach room temperature before opening to reduce condensation uptake.

Important Notes

Evidence remains preliminary, with limited human data and predominant oral administration in reports. SC dosing parameters are not clinically established for Pinealon^[4][5].

• Use new sterile insulin syringes; dispose in a sharps container.
• Rotate injection sites (abdomen, thighs, upper arms) to reduce local irritation.
• Inject slowly; wait a few seconds before withdrawing the needle.
• Document daily dose and site rotation for consistency.

How This Works

EDR/Pinealon may interact with chromatin and regulatory elements, modulating gene expression relevant to neuronal stress responses and plasticity; experimental models show antioxidant effects and preservation of dendritic spines^{[1][3][5][6][7]}. Animal and cellular studies report improved viability under oxidative stress and cognitive/behavioral signals after exposure^[1][2].

Potential Benefits & Side Effects

Observations from preclinical and review literature.

• Neuroprotective and anti‑oxidative signals in vitro and in vivo models^[1][2].
• Epigenetic modulation and preservation of neuronal structures (spines/synapses) in models^[5][6][7].
• Human evidence remains limited and heterogeneous; safety/tolerability for SC use is not characterized in controlled trials^[4][5].
• Subcutaneous injections may cause mild local reactions (redness/itch); rotate sites to avoid lipohypertrophy^[8][11].

Lifestyle Factors

Complementary strategies for rigorous research protocols.

• Standardize sleep/wake windows and minimize confounders (caffeine/alcohol) when studying cognition.
• Maintain consistent nutrition and training plans to reduce variability.
• Track outcomes with validated tools (e.g., reaction time, memory tasks) pre/post exposure.

Injection Technique

General subcutaneous guidance from authoritative resources^{[8][9][10][11]}.

• Clean the vial stopper and skin with alcohol; allow to dry.
• Pinch a skinfold; insert the needle at 45–90° into subcutaneous tissue^[8].
• Aspiration is not recommended for routine subcutaneous vaccine‑type injections^[9][11].
• Rotate sites (abdomen, thighs, upper arms) to prevent lipohypertrophy and ensure consistent absorption^[10].

Recommended Source

Note: Product availability and specifications subject to change. Verify current product details on supplier website.

Shop at Amino Labs

References